clinical research

Photo

Novotech Boosts US Presence with NCGS Buy

Asia-Pacific contract research organization (CRO) Novotech has acquired NCGS, a US CRO with about 300 employees and a biopharma client base. Financial terms of the transaction were not disclosed. “This is a strategic move to provide US-based expertise and infrastructure for our US clients wanting trials in Asia-Pacific and the US, and for our Asia-Pacific clients wanting US clinical program, said Novotech CEO John Moller.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.